| Literature DB >> 28514449 |
Gaojie Song1, Dehua Yang2, Yuxia Wang1, Chris de Graaf3, Qingtong Zhou1, Shanshan Jiang4, Kaiwen Liu1,5,6, Xiaoqing Cai2, Antao Dai2, Guangyao Lin5, Dongsheng Liu1, Fan Wu1,5,6, Yiran Wu1, Suwen Zhao1,5, Li Ye4, Gye Won Han7, Jesper Lau8, Beili Wu5,6,9, Michael A Hanson10, Zhi-Jie Liu1,5,11, Ming-Wei Wang2,4,5, Raymond C Stevens1,5.
Abstract
The glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR) are members of the secretin-like class B family of G-protein-coupled receptors (GPCRs) and have opposing physiological roles in insulin release and glucose homeostasis. The treatment of type 2 diabetes requires positive modulation of GLP-1R to inhibit glucagon secretion and stimulate insulin secretion in a glucose-dependent manner. Here we report crystal structures of the human GLP-1R transmembrane domain in complex with two different negative allosteric modulators, PF-06372222 and NNC0640, at 2.7 and 3.0 Å resolution, respectively. The structures reveal a common binding pocket for negative allosteric modulators, present in both GLP-1R and GCGR and located outside helices V-VII near the intracellular half of the receptor. The receptor is in an inactive conformation with compounds that restrict movement of the intracellular tip of helix VI, a movement that is generally associated with activation mechanisms in class A GPCRs. Molecular modelling and mutagenesis studies indicate that agonist positive allosteric modulators target the same general region, but in a distinct sub-pocket at the interface between helices V and VI, which may facilitate the formation of an intracellular binding site that enhances G-protein coupling.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28514449 DOI: 10.1038/nature22378
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962